Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
aap Implantate AG is a medical technology company based in Berlin, Germany, specializing in the development, manufacturing, and marketing of trauma products for orthopedics. Its core offerings include the LOQTEQ® anatomical plating system and a range of cannulated screws designed for fracture treatment. The company is also advancing technologies such as antibacterial silver coating and magnesium-based implants to address unmet needs in trauma care. Founded in 1990, aap Implantate AG operates directly in Germany and through a network of distributors in approximately 25 countries, with a hybrid distribution strategy in the United States via its subsidiary, aap Implants Inc. In 2023, the company established a research and development and production headquarters in Suzhou New District, China, to conduct clinical trials on high-end silver ion anti-infection implants. This strategic expansion aims to enhance its presence in the Chinese market and leverage the region's favorable business environment.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
aap Implantate AGJohnson & Johnson
Last price
€1.40$283.52
Currency
EUR
USD
€19M$675B
-42.59
-€0.19$6.58
0.280.21
0$5.28
01.91%
Sector
HealthHealth
Employees
105138,200
Ticker
€AAQ1$JNJ
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €AAQ1 or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.